HealthStream (NASDAQ:HSTM) Receives Media Sentiment Rating of 0.11

News articles about HealthStream (NASDAQ:HSTM) have been trending somewhat positive this week, Accern reports. The research group identifies positive and negative press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. HealthStream earned a media sentiment score of 0.11 on Accern’s scale. Accern also assigned media headlines about the technology company an impact score of 46.6318342907721 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Several research firms have commented on HSTM. First Analysis upgraded shares of HealthStream from an “underweight” rating to an “equal weight” rating and set a $19.00 price target for the company in a report on Wednesday, July 26th. Zacks Investment Research upgraded shares of HealthStream from a “sell” rating to a “hold” rating in a report on Tuesday, April 25th. Cantor Fitzgerald restated a “neutral” rating and issued a $24.00 target price (down previously from $28.00) on shares of HealthStream in a report on Wednesday, July 26th. Robert W. Baird restated an “outperform” rating and issued a $35.00 target price on shares of HealthStream in a report on Tuesday, June 27th. Finally, Needham & Company LLC upped their target price on shares of HealthStream from $28.00 to $32.00 and gave the company a “buy” rating in a report on Wednesday, April 26th. One analyst has rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the stock. HealthStream currently has an average rating of “Hold” and an average target price of $26.43.

Shares of HealthStream (NASDAQ HSTM) traded up 1.42% on Friday, hitting $22.91. 257,991 shares of the stock traded hands. The firm has a market cap of $730.51 million, a P/E ratio of 164.82 and a beta of 0.98. HealthStream has a 12-month low of $20.60 and a 12-month high of $31.53. The firm’s 50-day moving average is $24.74 and its 200 day moving average is $25.33.

HealthStream (NASDAQ:HSTM) last released its quarterly earnings results on Monday, July 24th. The technology company reported $0.08 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.04. HealthStream had a net margin of 1.85% and a return on equity of 2.27%. The business had revenue of $61.48 million during the quarter, compared to the consensus estimate of $61.36 million. During the same quarter last year, the company earned $0.04 earnings per share. The business’s quarterly revenue was up 12.2% compared to the same quarter last year. Equities research analysts forecast that HealthStream will post $0.22 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by Transcript Daily and is owned by of Transcript Daily. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://transcriptdaily.com/2017/08/13/healthstream-nasdaqhstm-receives-media-sentiment-rating-of-0-11.html.

About HealthStream

HealthStream, Inc (HealthStream) provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions and HealthStream Provider Solutions. HealthStream’s products and services are organized into three segments: Workforce Solutions, Patient Experience Solutions, and Provider Solutions.

Insider Buying and Selling by Quarter for HealthStream (NASDAQ:HSTM)

Receive News & Ratings for HealthStream Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply